$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

$nvos Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223024727 Filed on July 17, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$3.303M	$3.293M
YoY Change	-71.86%	-76.23%
Cost Of Revenue	$2.375M	$1.979M
YoY Change	-65.77%	-82.71%
Gross Profit	$928.2K	$1.314M
YoY Change	-80.66%	-45.45%
Gross Profit Margin	28.1%	39.91%
Selling, General & Admin	$4.022M	$2.745M
YoY Change	-72.04%	-24.01%
% of Gross Profit	433.33%	208.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$582.8K	$579.6K
YoY Change	-13.0%	-34.26%
% of Gross Profit	62.78%	44.11%
Operating Expenses	$4.022M	$2.745M
YoY Change	-72.04%	-24.01%
Operating Profit	-$3.094M	-$1.430M
YoY Change	-67.72%	18.93%
Interest Expense	-$715.9K	-$54.88K
YoY Change	-91.1%	-110.69%
% of Operating Profit
Other Income/Expense, Net	$607.6K	-$54.88K
YoY Change		-97.84%
Pretax Income	-$3.202M	-$1.485M
YoY Change	-90.32%	-60.33%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.160M	-$1.497M
YoY Change	-90.38%	-60.7%
Net Earnings / Revenue	-95.68%	-45.47%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	-$0.21	-$0.01
COMMON SHARES
Basic Shares Outstanding	148.4M shares	144.9M shares
Diluted Shares Outstanding		14.36M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$416.3K	$464.0K
YoY Change	-80.89%	-96.34%
Cash & Equivalents	$416.3K	$464.0K
Short-Term Investments
Other Short-Term Assets	$346.2K	$221.4K
YoY Change	-39.41%	-41.86%
Inventory	$1.107M	$938.9K
Prepaid Expenses
Receivables	$1.467M	$1.328M
Other Receivables	$1.052M	$1.046M
Total Short-Term Assets	$4.388M	$3.998M
YoY Change	-23.44%	-80.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.390M	$7.508M
YoY Change	-7.08%	26.57%
Goodwill	$7.582M	$7.543M
YoY Change	-3.11%	-33.64%
Intangibles	$16.22M	$16.70M
YoY Change	-13.92%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$31.17M	$31.75M
YoY Change	-11.29%	-38.61%
TOTAL ASSETS
Total Short-Term Assets	$4.388M	$3.998M
Total Long-Term Assets	$31.17M	$31.75M
Total Assets	$35.56M	$35.75M
YoY Change	-12.99%	-50.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.514M	$1.896M
YoY Change	95.18%	16.92%
Accrued Expenses	$1.234M	$1.922M
YoY Change	10.52%	54.56%
Deferred Revenue	$35.43K	$35.64K
YoY Change	-3.94%
Short-Term Debt	$1.092M	$1.058M
YoY Change	-88.6%	-54.62%
Long-Term Debt Due	$1.206M	$1.239M
YoY Change	13465.47%	-76.53%
Total Short-Term Liabilities	$7.905M	$6.209M
YoY Change	-43.84%	-51.23%
LONG-TERM LIABILITIES
Long-Term Debt	$65.04K	$64.95K
YoY Change	-94.19%	-99.43%
Other Long-Term Liabilities	$1.694M	$1.787M
YoY Change	-22.5%	3.01%
Total Long-Term Liabilities	$1.759M	$1.852M
YoY Change	-46.79%	-85.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.905M	$6.209M
Total Long-Term Liabilities	$1.759M	$1.852M
Total Liabilities	$11.06M	$9.178M
YoY Change	-41.23%	-66.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.03M	-$63.87M
YoY Change	24.55%	103.47%
Common Stock	$15.76K	$144.9K
YoY Change	-49.46%	372.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.82M	$26.57M
YoY Change
Total Liabilities & Shareholders Equity	$35.56M	$35.75M
YoY Change	-12.99%	-50.21%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$3.160M	-$1.497M
YoY Change	-90.38%	-60.7%
Depreciation, Depletion And Amortization	$582.8K	$579.6K
YoY Change	-13.0%	-34.26%
Cash From Operating Activities	-$233.3K	-$857.7K
YoY Change	-134.53%	-75.84%
INVESTING ACTIVITIES
Capital Expenditures	$29.22K	$18.87K
YoY Change	-3752.5%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$29.22K	-$18.87K
YoY Change	-3707.41%	-105.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	463.9K	901.0K
YoY Change	-104.13%	-2519.52%
NET CHANGE
Cash From Operating Activities	-233.3K	-857.7K
Cash From Investing Activities	-29.22K	-18.87K
Cash From Financing Activities	463.9K	901.0K
Net Change In Cash	201.3K	24.44K
YoY Change	-101.91%	-100.75%
FREE CASH FLOW
Cash From Operating Activities	-$233.3K	-$857.7K
Capital Expenditures	$29.22K	$18.87K
Free Cash Flow	-$262.5K	-$876.6K
YoY Change	-138.81%	-75.31%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q3	us-gaap	Other Liability Current Related And Nonrelated Party Status Extensible Enumeration OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt		usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001138978
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent		usd
CY2022Q3	NVOS	Debentures Related Parties Current DebenturesRelatedPartiesCurrent		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	NVOS	Issuance Of Common Stock To Be Issued IssuanceOfCommonStockToBeIssued		shares
CY2023Q1	NVOS	Issuance Of Common Stock To Be Issued IssuanceOfCommonStockToBeIssued		shares
CY2021Q4	NVOS	Stock Issued During Period Value Common Stock Issued To Be Held In Escrow StockIssuedDuringPeriodValueCommonStockIssuedToBeHeldInEscrow		usd
CY2022Q2	NVOS	Issuance Of Common Stock To Be Issued IssuanceOfCommonStockToBeIssued		shares
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	NVOS	Financing Costs For Debt Extension FinancingCostsForDebtExtension		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	us-gaap	Proceeds From Collection Of Other Receivables ProceedsFromCollectionOfOtherReceivables		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NVOS	Common Stock Issued For Intangible Assets CommonStockIssuedForIntangibleAssets		usd
	NVOS	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	NVOS	Beneficial Conversion Feature Upon Issuance Of Convertible Notes BeneficialConversionFeatureUponIssuanceOfConvertibleNotes		usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability		usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote		usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions		usd
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes		usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes		usd
	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs		usd
CY2023Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2022Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2022Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent		usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022Q2	NVOS	Capital Expenditures CapitalExpenditures		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-05-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40089
	dei	Entity Registrant Name EntityRegistrantName	Novo Integrated Sciences, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3691650
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11120 NE 2nd Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bellevue
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98004
	dei	City Area Code CityAreaCode	(206)
	dei	Local Phone Number LocalPhoneNumber	617-9797
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	NVOS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	148434184	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	464011	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2178687	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1327613	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1017405	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	938940	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	879033	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1046080	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1085335	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	221414	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	571335	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	3998058	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	5731795	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5411438	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5800648	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16696363	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	18840619	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2096376	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2673934	usd
CY2023Q2	us-gaap	Goodwill Goodwill	7542795	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2023Q2	us-gaap	Assets Assets	35745030	usd
CY2022Q3	us-gaap	Assets Assets	40872840	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1896040	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1800268	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1178245	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1116125	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	350831	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	454189	usd
CY2023Q2	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	312672	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	494523	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	494523	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	651477	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9099654	usd
CY2023Q2	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	57933	usd
CY2022Q3	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	534595	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	406683	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	478897	usd
CY2023Q2	NVOS	Debentures Related Parties Current DebenturesRelatedPartiesCurrent	912025	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	13814	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8890	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	428951	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582088	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6208671	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14074706	usd
CY2022Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	946250	usd
CY2023Q2	NVOS	Notes And Loan Payable Non Current NotesAndLoanPayableNonCurrent	64946	usd
CY2022Q3	NVOS	Notes And Loan Payable Non Current NotesAndLoanPayableNonCurrent	161460	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	12076	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1786961	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1978839	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	11443001	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5244192	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14991331	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2185329	usd
CY2023Q2	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1393168	usd
CY2022Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1445448	usd
CY2023Q2	us-gaap	Liabilities Liabilities	9453746	usd
CY2022Q3	us-gaap	Liabilities Liabilities	18825269	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	144857518	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	144857518	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31180603	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31180603	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	144857	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	31181	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89249590	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66056824	usd
CY2023Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	911392	shares
CY2022Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	4149633	shares
CY2023Q2	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	1217293	usd
CY2022Q3	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	9474807	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-172526	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	560836	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63872587	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53818489	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	26566627	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	22305159	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	-275343	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	-257588	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26291284	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35745030	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40872840	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3292933	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13851883	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9268722	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19883033	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1314094	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2408882	usd
	us-gaap	Gross Profit GrossProfit	4024530	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12035	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	66029	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-13095	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6816	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1497330	usd
	us-gaap	Gross Profit GrossProfit	4891702	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	1877	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	9802	usd
	us-gaap	Selling Expense SellingExpense	9916	usd
	us-gaap	Selling Expense SellingExpense	36340	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2742635	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3601826	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9473802	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9542443	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2744512	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3611628	usd
	us-gaap	Operating Expenses OperatingExpenses	9483718	usd
	us-gaap	Operating Expenses OperatingExpenses	9578783	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1430418	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1202746	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5459188	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4687081	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	62397	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	8355	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6762	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	25233	usd
CY2023Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9570	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	513398	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	240520	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1808310	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	156037	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2133890	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4386899	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3654752	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	48333	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	97654	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12652	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-303714	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-54877	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2541279	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4608005	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5741543	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1485295	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3744025	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10067193	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10428624	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3810054	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10054098	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10421808	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-120357	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13711	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-738022	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24916	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1605652	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3730314	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10805215	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10403708	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	143600541	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29817999	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85832252	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28498414	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	22047571	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1795000	usd
CY2022Q4	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	1139050	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-420982	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-3936736	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20684790	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9086051	usd
CY2023Q1	NVOS	Stock Issued During Period Value Cashless Exercise Of Warrants StockIssuedDuringPeriodValueCashlessExerciseOfWarrants	282533	usd
CY2023Q1	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	131000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	82963	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	86327	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	60887	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	1390380	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-196683	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4645162	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26963086	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	100278	usd
CY2023Q2	NVOS	Stock Issued During Period Value Exercise Of Warrants For Cash StockIssuedDuringPeriodValueExerciseOfWarrantsForCash	320000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	90132	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	93811	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	66068	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	263561	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-120357	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26291284	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43804155	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	64750	usd
CY2021Q4	NVOS	Common Stock To Be Issued For Purchase Of Terragenx CommonStockToBeIssuedForPurchaseOfTerragenx	1081236	usd
CY2021Q4	NVOS	Common Stock To Be Issued For Purchase Of Mullin Assets CommonStockToBeIssuedForPurchaseOfMullinAssets	188925	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	295824	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	154135	usd
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-104388	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-1816395	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43668242	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	298000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5257466	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	44427	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	115093	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4868204	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44515024	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	314000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1247849	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1704000	usd
CY2022Q2	NVOS	Common Stock To Be Issued For Acquisitions CommonStockToBeIssuedForAcquisitions	286027	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	91330	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	13762	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	13762	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44427967	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1718388	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2349434	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-385335	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-289892	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	676750	usd
	NVOS	Financing Costs For Debt Extension FinancingCostsForDebtExtension	-1421583	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	624246	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	418188	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4386899	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3654752	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	12652	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-303714	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	308907	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3650069	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	92260	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	263539	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-333724	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	150632	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	154542	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	117056	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	104004	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-68871	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-67634	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	598904	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-594618	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-406862	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2014543	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6559907	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18870	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	190973	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	57489	usd
	us-gaap	Proceeds From Collection Of Other Receivables ProceedsFromCollectionOfOtherReceivables	296138	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18870	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	162654	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	56649	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	21932	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6435	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	14797	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	222000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-4430794	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1795000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	451000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3033888	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	925306	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15270000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	296334	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10802477	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22403	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-20940	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1714676	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4384284	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2178687	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8293162	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	464011	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12677446	usd
	us-gaap	Interest Paid Net InterestPaidNet	343878	usd
	us-gaap	Interest Paid Net InterestPaidNet	1294912	usd
	NVOS	Common Stock Issued For Convertible Debt CommonStockIssuedForConvertibleDebt	9186329	usd
	NVOS	Common Stock Issued For Convertible Debt CommonStockIssuedForConvertibleDebt	1247849	usd
	NVOS	Common Stock Issued For Intangible Assets CommonStockIssuedForIntangibleAssets	188925	usd
	NVOS	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	1244550	usd
	us-gaap	Stock Issued1 StockIssued1	1704000	usd
	NVOS	Beneficial Conversion Feature Upon Issuance Of Convertible Notes BeneficialConversionFeatureUponIssuanceOfConvertibleNotes	66068	usd
	NVOS	Debt Discount Recognized On Derivative Liability DebtDiscountRecognizedOnDerivativeLiability	1390380	usd
	NVOS	Debt Discount Recognized On Convertible Note DebtDiscountRecognizedOnConvertibleNote	639993	usd
	NVOS	Extinguishment Of Derivative Liability Due To Conversions ExtinguishmentOfDerivativeLiabilityDueToConversions	1390380	usd
	NVOS	Common Stock Issued With Convertible Notes CommonStockIssuedWithConvertibleNotes	173095	usd
	NVOS	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	180138	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zTLo7csIs1q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span><span id="xdx_86A_zoCIh018kbj7">Use of Estimates</span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to going concern assessment, useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, valuation of share-based compensation and warrants, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1095710	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	992329	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	990501	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1027670	usd
	NVOS	Other Receivable Write Offs OtherReceivableWriteOffs	299672	usd
CY2023Q2	NVOS	Other Receivable Prinicipal Amount OtherReceivablePrinicipalAmount	225924	usd
CY2023Q2	us-gaap	Interest Receivable And Other Assets InterestReceivableAndOtherAssets	73748	usd
	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_892_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_zWqfRhV9c5gb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_z6lTOXmwRMki" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_zeqXuLMRR3H2" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zcjQoEoUrqOh" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z9NTk6Abojb3" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20230531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_z7Jw9QHKi0p5" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1357043	usd
CY2021Q3	us-gaap	Goodwill Goodwill	9488848	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	602	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1357043	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-306563	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-283049	usd
CY2023Q2	us-gaap	Goodwill Goodwill	7542795	usd
CY2023Q2	us-gaap	Goodwill Goodwill	7542795	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_846_eus-gaap--DerivativesReportingOfDerivativeActivity_zc6mT9pEodme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zgmyA1MXkAMi">Derivative Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments and measurement of their fair value for accounting purposes. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt under ASC 470, the Company will continue its evaluation process of these instruments as derivative financial instruments under ASC 815. The Company applies the guidance in ASC 815-40-35-12 to determine the order in which each convertible instrument would be evaluated for derivative classification.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to the fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-738022	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-431605	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	integer
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zu4a1li0a8W9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_z5hP2eOq0fOj">Reclassifications</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period. These reclassifications had no effect on the net loss or stockholders’ equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	NVOS	Trade Receivables TradeReceivables	2387505	usd
CY2022Q3	NVOS	Trade Receivables TradeReceivables	1829475	usd
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	35818	usd
CY2022Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	180259	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2423323	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2009734	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1095710	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	992329	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1327613	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1017405	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	704191	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1259954	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	134293	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	139333	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1090957	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	507416	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	1929441	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	1906703	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	990501	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1027670	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	938940	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	879033	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	1046080	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	1085335	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1046080	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1085335	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6578576	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6805380	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1167138	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1004732	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5411438	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5800648	usd
	us-gaap	Depreciation Depreciation	212579	usd
	us-gaap	Depreciation Depreciation	408589	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23257389	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23943175	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6561026	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5102556	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16696363	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18840619	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1505809	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1940845	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2002272	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2002272	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1569690	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1374673	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	999187	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	8748269	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16696363	usd
CY2023Q2	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	898009	usd
CY2022Q3	NVOS	Accrued Liabilities Gross Current AccruedLiabilitiesGrossCurrent	884024	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	244595	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	195214	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35641	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	36887	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1178245	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1116125	usd
CY2023Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	377618	usd
CY2022Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	161460	usd
CY2023Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	312672	usd
CY2023Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	64946	usd
CY2022Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	161460	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-12-31
	us-gaap	Debt Instrument Description DebtInstrumentDescription	If the loan amount is paid on or before December 31, 2023, 25% of the loan will be forgiven (“Early Payment Credit”). In the event that the Company does not repay 75% of such term debt on or before December 31, 2023, the Early Payment Credit will not apply.
	NVOS	Debt Instrument Forgiveness Applicable Repayment Rate DebtInstrumentForgivenessApplicableRepaymentRate	0.25	pure
	NVOS	Debt Instrument Default Repayment Percentage DebtInstrumentDefaultRepaymentPercentage	0.75	pure
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	20000	cad
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	312672	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4777	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4777	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	4777	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	4777	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	45838	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	377618	usd
CY2020Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	267768	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	912025	usd
CY2022Q3	us-gaap	Debt Current DebtCurrent	946250	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2096376	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2673934	usd
CY2023Q2	NVOS	Operating Lease Assets OperatingLeaseAssets	2096376	usd
CY2022Q3	NVOS	Operating Lease Assets OperatingLeaseAssets	2673934	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	428951	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	582088	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1786961	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2185329	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2215912	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2767417	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	601370	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	524288	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	502177	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	495008	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	295839	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	358487	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2777169	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	561257	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2215912	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	428951	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1786961	usd
	us-gaap	Payments For Rent PaymentsForRent	624246	usd
	us-gaap	Payments For Rent PaymentsForRent	567772	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	604387	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	556445	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M9D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	209457	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	192347	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17110	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	14054	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	14054	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	240	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	13814	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	13814	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	144857518	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	144857518	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31180603	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31180603	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4000000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2164235	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M10D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	140577	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2000000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.13
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P6Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4164235	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.19
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M10D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4164235	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.19
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M10D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4164235	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4164235	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.13
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.37
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	385335	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	289892	usd
CY2023Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0374	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.54	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.81	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	8445264	shares
CY2022Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	2.42
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	10000000	shares
	NVOS	Share Based Compensation Arrangements By Share Based Payment Award Non Option Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionGrantsInPeriodWeightedAverageExercisePrice	0.13
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionGrantedWeightedAverageRemainingContractualTerm2	P4Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	10343334	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	8101930	shares
CY2023Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	1.18
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm3	P3Y9M29D
CY2023Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue	111680	usd
CY2023Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableNumber	8101930	shares
CY2023Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisableWeightedAverageExercisePrice	1.18
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M29D
CY2023Q2	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisableIntrinsicValue1	111680	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3292933	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13851883	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9268722	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19883033	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1314094	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2408882	usd
	us-gaap	Gross Profit GrossProfit	4024530	usd
	us-gaap	Gross Profit GrossProfit	4891702	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1430418	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1202746	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5459188	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4687081	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	579591	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	881597	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1718388	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2349434	usd
CY2023Q2	NVOS	Capital Expenditures CapitalExpenditures	18870	usd
	NVOS	Capital Expenditures CapitalExpenditures	18870	usd
	NVOS	Capital Expenditures CapitalExpenditures	190973	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	9570	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	513398	usd
	us-gaap	Interest Expense InterestExpense	240520	usd
	us-gaap	Interest Expense InterestExpense	1808310	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1485295	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
	us-gaap	Profit Loss ProfitLoss	-10067193	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
CY2023Q2	us-gaap	Assets Assets	35745030	usd
CY2022Q3	us-gaap	Assets Assets	40872840	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1327613	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1017405	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16696363	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18840619	usd
CY2023Q2	us-gaap	Goodwill Goodwill	7542795	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7825844	usd

Files In Submission

Name	View Source	Status
0001493152-23-024727-index-headers.html	Edgar Link	pending
0001493152-23-024727-index.html	Edgar Link	pending
0001493152-23-024727.txt	Edgar Link	pending
0001493152-23-024727-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvos-20230531.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
nvos-20230531_cal.xml	Edgar Link	unprocessable
nvos-20230531_def.xml	Edgar Link	unprocessable
nvos-20230531_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nvos-20230531_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

2023 Q3 Form 10-Q Financial Statement

#000149315223024727 Filed on July 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS Novo Integrated Sciences, Inc. Stock $nvos

2023 Q3 Form 10-Q Financial Statement

#000149315223024727 Filed on July 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos